| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Focal adhesion |
8 genes: COL5A1, RAPGEF1, ITGA5, KDR, COL5A3, PTEN, ROCK1, CCND2
|
0.001277 |
| Axon guidance |
6 genes: PLXNC1, L1CAM, NFATC4, PPP3CA, ROCK1, NTN1
|
0.00253 |
| GnRH signaling pathway |
5 genes: ADCY5, HBEGF, MAP3K3, MMP2, MMP14
|
0.004267 |
| Wnt signaling pathway |
6 genes: DAAM1, NFATC4, PPP3CA, ROCK1, FZD4, CCND2
|
0.005274 |
| MAPK signaling pathway |
8 genes: FGF13, MRAS, FOS, MAP3K3, NFATC4, PPP3CA, DUSP22, BDNF
|
0.007551 |
| Regulation of actin cytoskeleton |
7 genes: FGF13, MRAS, ITGA5, PIP4K2A, SSH1, ENAH, ROCK1
|
0.007581 |
| PI3K AKT signaling pathway |
9 genes: FGF13, BDNF, KDR, IL2RA, ITGA5, PTEN, CCND2, CREB5, MCL1
|
0.01214 |
| Circadian rhythm . mammal |
2 genes: PER1, RORA
|
0.02402 |
| Glycosaminoglycan biosynthesis . heparan sulfate |
2 genes: NDST1, XYLT1
|
0.03023 |
| B cell receptor signaling pathway |
3 genes: FOS, NFATC4, PPP3CA
|
0.04442 |
| VEGF signaling pathway |
3 genes: KDR, NFATC4, PPP3CA
|
0.0459 |